Beacon platform study for prostate surgery
Part of Kidney & urinary clinical trials.
This trial tests a new surgical platform called Beacon during HoLEP, a common procedure to treat enlarged prostate symptoms. It may help men with difficulty urinating due to an enlarged prostate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be male and at least 45 years old.
- You have trouble urinating or can't urinate because your prostate is enlarged.
- Your prostate size is between 40 and 120 cc (about the size of a small apple to a large peach), measured by ultrasound, MRI, or CT scan in the last year.
- You are scheduled to have a procedure called HoLEP to treat your prostate.
- You can stop taking blood thinners like warfarin or clopidogrel a few days before the procedure (low-dose aspirin is okay).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device called Optilume BPH Catheter System for men with enlarged prostate that causes bothersome urinary symptoms. It aims to see how safe and effective it is in real-world use, offering a possible treatment for blocked urine flow without surgery.
This study tests whether patients with enlarged prostates can benefit from an exercise and education program before undergoing a laser procedure to remove prostate tissue. The goal is to see if preparing your body beforehand helps with recovery and outcomes.
This trial tests a new treatment that uses focused sound waves to break down extra prostate tissue without cutting or heat. It may help men with an enlarged prostate who have bothersome urinary symptoms.
This trial compares two laser treatments for an enlarged prostate (benign prostatic hyperplasia, or BPH) in men whose symptoms did not improve with medicine. It may help find which laser approach works better for improving urine flow and symptom relief.
This trial tests a new tool (the Beacon Platform) that helps doctors perform a type of laser surgery for an enlarged prostate, called HoLEP. The goal is to see if it makes the surgery easier and more effective, which could help you urinate better.
This study measures how much prostate tissue is removed during a minimally invasive laser surgery (HoLEP) and tests whether the amount removed can predict how much your urinary symptoms improve. Understanding this connection may help doctors better predict surgery outcomes for men with urinary problems.
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.